NCT02582697 | AGCT1532 | COG-AYA
A Randomized Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients with Intermediate and Poor-Risk Germ Cell Tumors
NCT05136196 | S2101 | SWOG
Biomarker Stratified CaboZantinib (NSC#761968) and NivOlumab (NSC#748726) (BiCaZO) – A Phase II Study of Combining Cabozantinib and Nivolumab in Participants with Advanced Solid Tumors (IO Refractory Melanoma or HNSCC) Stratified by Tumor Biomarkers – an immunoMATCH Pilot Study
NCT07215624 | WF-2502CD | WAKE
Surgical Thromboprophylaxis Practices in Oncology Patients within the NCORP Network